Skip to main content
. Author manuscript; available in PMC: 2009 May 14.
Published in final edited form as: Osteoarthritis Cartilage. 2007 Mar 28;15(8):966–971. doi: 10.1016/j.joca.2007.02.014

Table 3.

Ln hsCRP and demographics and clinical characteristics.

Mean hsCRP (mg/L) Mean Ln hsCRP§ 95% Confidence Intervals of Ln hsCRP

Race** Caucasian 1.63 7.40 7.25 – 7.54
African American 2.76 7.93 7.78 – 8.07

Gender** Male 1.65 7.41 7.25 – 7.57
Female 2.51 7.83 7.69 – 7.97

Chronic Pulmonary Disease* No 2.01 7.61 7.50 – 7.72
Yes 3.19 8.07 7.73 – 8.40

Cardiovascular Disease No 2.03 7.62 7.50 – 7.74
Yes 2.37 7.77 7.54 – 8.00

Hypertension** No 1.77 7.48 7.35 – 7.61
Yes 2.80 7.94 7.77 – 8.11

Use of Pain Medication* No 1.86 7.53 7.40 – 7.66
Yes 2.64 7.88 7.71 – 8.05

Smoking No 2.18 7.69 7.57 – 7.81
Yes 1.76 7.47 7.23 – 7.71

Diabetes** No 1.94 7.57 7.46 – 7.68
Yes 3.64 8.20 7.92 – 8.49

Insulin Use* No 2.02 7.61 7.50 – 7.72
Yes 3.86 8.26 7.84 – 8.68

Ln hsCRP = natural logarithm of high-sensitivity C-reactive protein in serum (§for presentation purposes, hsCRP was expressed in μg/L prior to natural log transformation)

*

p < 0.05 compared to referent;

**

p < 0.0001 compared to referent